Tuesday, December 16, 2025 | 03:27 PM ISTहिंदी में पढें
Drugmaker Mylan
One shot every six months: India could change HIV prevention forever
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of generic production
 "One shot every six months: India could change HIV prevention forever")
Updated On : 30 Sep 2025 | 1:07 PM IST
Biocon gets a shot in the arm with FDA approval for insulin glargine
The drug will be major contributor in the firm's bid to reach $1 billion revenue target by FY22, says biologics CEO Hamacher
 "Biocon gets a shot in the arm with FDA approval for insulin glargine")
Updated On : 12 Jun 2020 | 8:08 PM IST
Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility
Biocon Biologics, through its partner Mylan, has commercialised three of its co-developed biosimilars in developed markets like the US, Canada, the European Union and Australia.
 "Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility")
Updated On : 27 Nov 2019 | 12:44 PM IST
Drugmaker Mylan's profit rises 6%; sets no timeline on strategic options
US generic drugmakers such as Mylan and Teva Pharmaceutical Industries Ltd have suffered over the past few years as a steep fall in generic prices weighed on their bottom lines
 "Drugmaker Mylan's profit rises 6%; sets no timeline on strategic options")
Updated On : 06 Nov 2018 | 6:57 AM IST
